Return on investment in pharma R&D rises with GLP-1 drugs helping drive growth
The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs helping to boost growth, according to analysis by Deloitte. Findings from the latest Measuring the Return from Pharmaceutical …